InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.84
(
0.18%
)
US TECH 100
19,283.60
(
0.36%
)
Dow Jones
39,245.69
(
0.30%
)
Brent Oil
85.28
(
0.95%
)
Bitcoin
62,022.50
(
1.99%
)
Post# of 146240
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JG36

Send PM Follow Ignore
Followers 10
Posts 4272
Boards Moderated 0
Alias Born 11/12/2012

JG36

Re: leifsmith post# 65707

Tuesday, 02/19/2013 9:02:58 PM

Tuesday, February 19, 2013 9:02:58 PM

Post# of 146240
I did assume that the costs will only be half the average. (Plenty of phase III trials cost $45,000 per patient or more.) A budget of "a few million" assumes you're only going to spend $3000 per patient. That sounds an awful lot like wishful thinking.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NNVC News
More NNVC News
InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM

North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM

Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!